Contact
Please use this form to send email to PR contact of this press release:
Incyte and Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA® (pembrolizumab)
TO:
Please use this form to send email to PR contact of this press release:
Incyte and Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA® (pembrolizumab)
TO: